Literature DB >> 32900907

The transvenous retrograde pressure cooker technique for the curative embolization of high-grade brain arteriovenous malformations.

Masaomi Koyanagi1, Pascal John Mosimann2, Hannes Nordmeyer2, Markus Heddier2, Juergen Krause2, Ana-Paula Narata2, Ahmed El Serwi2, Christian Paul Stracke2, René Chapot2.   

Abstract

BACKGROUND: Transvenous embolization of brain arteriovenous malformations (AVMs) can be curative. We aimed to evaluate the cure rate and safety of the transvenous retrograde pressure cooker technique (RPCT) using coils and n-butyl-2-cyanoacrylate as a venous plug.
METHODS: All AVM patients treated via transvenous embolization between December 2004 and February 2017 in a single center were extracted from our database. Inclusion criteria were: inability to achieve transarterial cure alone; AVM < 3 cm; and single main draining vein. Outcome measures were immediate and 90 days' angiographic AVM occlusion rate, and morbidity and mortality at 30 days and 12 months, according to the modified Rankin Scale (mRS) score.
RESULTS: Fifty-one patients (20 women; median age 47 years) were included. A majority (71%) were high grade (3 to 5 in the Spetzler-Martin classification). AVMs were deeply seated in 30 (59%) and cortical in 21 patients (41%). Thirty-three patients were previously embolized transarterially (65%). All patients but one were cured within a single session with the RPCT (96%). Cure was confirmed on follow-up digital subtraction angiography at 3 months in 82% of patients. Three patients experienced intracranial hemorrhage (6%), one requiring surgical evacuation. There were no deaths. One treatment-related major permanent deficit was observed (2.0%). Mean mRS before treatment, at 30 days, and 12 months after RPCT was 1.5, 1.5, and 1.3, respectively.
CONCLUSIONS: The retrograde pressure cooker technique can be curative in carefully selected high-grade AVMs. Long-term follow-up and prospective studies are needed to confirm our results. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  arteriovenous malformation; brain; liquid embolic material; vein

Mesh:

Year:  2020        PMID: 32900907     DOI: 10.1136/neurintsurg-2020-016566

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  7 in total

Review 1.  Endovascular Management of Intracranial Dural AVFs: Transvenous Approach.

Authors:  K D Bhatia; H Lee; H Kortman; J Klostranec; W Guest; T Wälchli; I Radovanovic; T Krings; V M Pereira
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-14       Impact factor: 3.825

2.  Clinical Outcome and Quality of Life of Multimodal Treatment of Extracranial Arteriovenous Malformations: The APOLLON Study Protocol.

Authors:  Vanessa F Schmidt; Max Masthoff; Veronika Vielsmeier; Caroline T Seebauer; Özlem Cangir; Lutz Meyer; Antje Mükke; Werner Lang; Axel Schmid; Peter B Sporns; Richard Brill; Walter A Wohlgemuth; Natascha Platz Batista da Silva; Max Seidensticker; Regina Schinner; Julia Küppers; Beate Häberle; Frank Haubner; Jens Ricke; Martin Zenker; Melanie A Kimm; Moritz Wildgruber
Journal:  Cardiovasc Intervent Radiol       Date:  2022-10-19       Impact factor: 2.797

3.  Perioperative Complications of Transvenous Embolization of Ruptured Intracranial Arteriovenous Malformations.

Authors:  Yanyan He; Weixing Bai; Bin Xu; Xiaoyu Kang; Jiangyu Xue; Yingkun He; Tianxiao Li
Journal:  Front Neurol       Date:  2022-03-30       Impact factor: 4.003

4.  Transvenous embolization of hemorrhagic brain arteriovenous malformations: Case reports and literature review.

Authors:  Xiheng Chen; Longhui Zhang; Haoyu Zhu; Yajie Wang; Liwei Fan; Leying Ni; Linggen Dong; Ming Lv; Peng Liu
Journal:  Front Neurol       Date:  2022-08-22       Impact factor: 4.086

Review 5.  Review of treatment and therapeutic targets in brain arteriovenous malformation.

Authors:  Peipei Pan; Shantel Weinsheimer; Daniel Cooke; Ethan Winkler; Adib Abla; Helen Kim; Hua Su
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-23       Impact factor: 6.960

6.  First Experience in the Control of the Venous Side of the Brain AVM.

Authors:  Stephan Waldeck; Rene Chapot; Christian von Falck; Matthias F Froelich; Marc Brockmann; Daniel Overhoff
Journal:  J Clin Med       Date:  2021-12-09       Impact factor: 4.241

Review 7.  Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas.

Authors:  Dominik F Vollherbst; René Chapot; Martin Bendszus; Markus A Möhlenbruch
Journal:  Clin Neuroradiol       Date:  2021-07-29       Impact factor: 3.649

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.